• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左旋咪唑单药治疗口腔扁平苔藓。

Levamisole monotherapy for oral lichen planus.

作者信息

Won Tai Hyok, Park Se Young, Kim Bo Suk, Seo Phil Seung, Park Seok Don

机构信息

Department of Dermatology, Wonkwang University School of Medicine, Iksan, Korea.

出版信息

Ann Dermatol. 2009 Aug;21(3):250-4. doi: 10.5021/ad.2009.21.3.250. Epub 2009 Aug 31.

DOI:10.5021/ad.2009.21.3.250
PMID:20523798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2861235/
Abstract

BACKGROUND

Several different kinds of drugs have been used to treat chronic oral lichen planus (OLP). During the last decade, there have been several reports demonstrating success with levamisole and low dose prednisolone therapy for treating OLP. However, some OLP patients who have underlying diseases such as diabetes, hypertension and malignancy are unable to take steroids.

OBJECTIVE

The aim of this study was to evaluate levamisole monotherapy for treating OLP.

METHODS

Eleven patients who had OLP were treated with levamisole between 2005 and 2007. The levamisole was administered at a dose 50 mg thrice daily for three consecutive days, but then it was not administered on the following four days.

RESULTS

After 2 weeks of treatment, 8 patients reported a partial response, 3 patients reported no response and no patients reported clearance of lesion. After 4 weeks of treatment, 6 patients reported a partial response, 3 patients reported no response and 2 patients reported clearance of lesion. Furthermore, after 3 months of treatment, 3 patients reported a partial response, 3 patients reported no response and 5 patients reported complete clearance of lesion. Clinical improvement was shown in 2 weeks, whilst the mean duration to achieve clearance of lesion was 6.2 weeks. Although 1 patient had mild itching, there were no significant adverse effects.

CONCLUSION

Levamisole monotherapy could be a successful and safe treatment option for patients with chronic OLP and who cannot take steroids.

摘要

背景

几种不同类型的药物已被用于治疗慢性口腔扁平苔藓(OLP)。在过去十年中,有几份报告表明左旋咪唑和低剂量泼尼松龙治疗OLP取得了成功。然而,一些患有糖尿病、高血压和恶性肿瘤等基础疾病的OLP患者无法服用类固醇。

目的

本研究的目的是评估左旋咪唑单药治疗OLP的效果。

方法

2005年至2007年期间,11例OLP患者接受了左旋咪唑治疗。左旋咪唑的给药剂量为每日三次,每次50毫克,连续服用三天,随后四天不服用。

结果

治疗2周后,8例患者报告有部分缓解,3例患者报告无反应,无患者报告病损清除。治疗4周后,6例患者报告有部分缓解,3例患者报告无反应,2例患者报告病损清除。此外,治疗3个月后,3例患者报告有部分缓解,3例患者报告无反应,5例患者报告病损完全清除。2周时显示出临床改善,而达到病损清除的平均时间为6.2周。虽然1例患者有轻度瘙痒,但无明显不良反应。

结论

对于患有慢性OLP且不能服用类固醇的患者,左旋咪唑单药治疗可能是一种成功且安全的治疗选择。

相似文献

1
Levamisole monotherapy for oral lichen planus.左旋咪唑单药治疗口腔扁平苔藓。
Ann Dermatol. 2009 Aug;21(3):250-4. doi: 10.5021/ad.2009.21.3.250. Epub 2009 Aug 31.
2
Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia.左旋咪唑加泼尼松龙治疗口腔扁平苔藓患者的疗效,重点是左旋咪唑引起的粒细胞缺乏症或全血细胞减少症。
J Formos Med Assoc. 2019 Aug;118(8):1193-1201. doi: 10.1016/j.jfma.2019.03.007. Epub 2019 Mar 25.
3
Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Dec;80(6):705-9. doi: 10.1016/s1079-2104(05)80255-0.
4
Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.血清白细胞介素-6水平是评估左旋咪唑和中药对口腔扁平苔藓患者治疗效果的有用标志物。
J Oral Pathol Med. 2002 Apr;31(4):196-203. doi: 10.1034/j.1600-0714.2002.310402.x.
5
Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study.41例慢性口腔溃疡患者对左旋咪唑和低剂量泼尼松龙的反应:一项为期3年的开放性临床试验及随访研究
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Oct;86(4):438-45. doi: 10.1016/s1079-2104(98)90370-5.
6
Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.左旋咪唑对口腔扁平苔藓患者血清抗甲状腺球蛋白和抗甲状腺微粒体自身抗体水平的调节作用。
J Formos Med Assoc. 2011 Mar;110(3):169-74. doi: 10.1016/S0929-6646(11)60027-2.
7
Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus.左旋咪唑治疗口腔扁平苔藓患者血清抗核抗体水平的调节。
J Formos Med Assoc. 2011 May;110(5):316-21. doi: 10.1016/S0929-6646(11)60047-8.
8
Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus.左旋咪唑治疗口腔扁平苔藓患者血清平滑肌抗体水平的调节。
J Formos Med Assoc. 2013 Jun;112(6):352-7. doi: 10.1016/j.jfma.2013.03.003. Epub 2013 Apr 18.
9
Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.在监测口腔扁平苔藓的疾病活动方面,血清白细胞介素-8水平是比血清白细胞介素-6水平更敏感的标志物。
Br J Dermatol. 2005 Jun;152(6):1187-92. doi: 10.1111/j.1365-2133.2005.06497.x.
10
Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.左旋咪唑对复发性阿弗他溃疡或口腔扁平苔藓患者的免疫调节作用。
J Oral Pathol Med. 1994 Apr;23(4):172-7. doi: 10.1111/j.1600-0714.1994.tb01108.x.

引用本文的文献

1
Systemic non-steroidal immunomodulators for oral lichen planus treatment-a scoping review.系统性非甾体类免疫调节剂治疗口腔扁平苔藓的疗效评价:系统评价。
Clin Oral Investig. 2023 Dec;27(12):7091-7114. doi: 10.1007/s00784-023-05357-9. Epub 2023 Nov 3.
2
Effect of a Single and Triple Dose of Levamisole on Hematological Parameters in Controlled Inflammation Model.单剂量和三剂量左旋咪唑对可控炎症模型血液学参数的影响
Animals (Basel). 2022 Aug 17;12(16):2110. doi: 10.3390/ani12162110.
3
Acquired White Oral Lesions with Specific Patterns: Oral Lichen Planus and Lupus Erythematosus.具有特定形态的后天性白色口腔病变:口腔扁平苔藓和红斑狼疮。
Dermatol Pract Concept. 2021 May 20;11(3):e2021074. doi: 10.5826/dpc.1103a74. eCollection 2021 May.
4
Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial.左旋咪唑治疗非住院 COVID-19 患者临床症状的疗效和安全性:一项双盲、随机、对照试验。
BMC Infect Dis. 2021 Mar 24;21(1):297. doi: 10.1186/s12879-021-05983-2.
5
Anti-helminthic drugs in recurrent apthous stomatitis: A short review.复发性阿弗他口炎中的抗蠕虫药物:简短综述。
J Pharm Bioallied Sci. 2014 Apr;6(2):65-8. doi: 10.4103/0975-7406.129169.
6
The effect of levamisole on mortality rate among patients with severe burn injuries.左旋咪唑对严重烧伤患者死亡率的影响。
J Res Med Sci. 2013 Sep;18(9):795-800.

本文引用的文献

1
A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.左旋咪唑治疗局限性及缓慢进展性白癜风的随机安慰剂对照双盲研究。
Br J Dermatol. 2005 Jul;153(1):163-6. doi: 10.1111/j.1365-2133.2005.06556.x.
2
Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.在监测口腔扁平苔藓的疾病活动方面,血清白细胞介素-8水平是比血清白细胞介素-6水平更敏感的标志物。
Br J Dermatol. 2005 Jun;152(6):1187-92. doi: 10.1111/j.1365-2133.2005.06497.x.
3
Response of oral lichen planus to topical tacrolimus in 37 patients.37例口腔扁平苔藓患者局部应用他克莫司的疗效
Arch Dermatol. 2004 Dec;140(12):1508-12. doi: 10.1001/archderm.140.12.1508.
4
Treatment of erosive oral lichen planus with topical tacrolimus.外用他克莫司治疗糜烂性口腔扁平苔藓。
J Dermatolog Treat. 2004 Sep;15(5):308-14. doi: 10.1080/09546630410018247.
5
The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients.口腔扁平苔藓的临床特征、恶性潜能及全身关联:一项对723例患者的研究
J Am Acad Dermatol. 2002 Feb;46(2):207-14. doi: 10.1067/mjd.2002.120452.
6
Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus.外用他克莫司治疗顽固性溃疡性口腔扁平苔藓
J Am Acad Dermatol. 2002 Jan;46(1):35-41. doi: 10.1067/mjd.2002.120535.
7
The management of oral lichen planus.口腔扁平苔藓的管理
Oral Dis. 1999 Jul;5(3):196-205. doi: 10.1111/j.1601-0825.1999.tb00301.x.
8
Comparison of combination of cimetidine and levamisole with cimetidine alone in the treatment of recalcitrant warts.西咪替丁与左旋咪唑联合用药和单独使用西咪替丁治疗顽固性疣的比较。
Australas J Dermatol. 1999 May;40(2):93-5. doi: 10.1046/j.1440-0960.1999.00328.x.
9
Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study.41例慢性口腔溃疡患者对左旋咪唑和低剂量泼尼松龙的反应:一项为期3年的开放性临床试验及随访研究
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Oct;86(4):438-45. doi: 10.1016/s1079-2104(98)90370-5.
10
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.氟尿嘧啶+亚叶酸钙与氟尿嘧啶+左旋咪唑联合静脉及腹腔化疗用于切除术后结肠癌的辅助治疗
Br J Cancer. 1998 Apr;77(8):1349-54. doi: 10.1038/bjc.1998.225.